A detailed history of Fmr LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 11,639 shares of STRO stock, worth $9,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,639
Previous 61,549 81.09%
Holding current value
$9,427
Previous $40,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$0.52 - $1.3 $25,953 - $64,883
-49,910 Reduced 81.09%
11,639 $8,000
Q1 2025

May 12, 2025

SELL
$0.65 - $2.12 $140,622 - $458,647
-216,343 Reduced 77.85%
61,549 $40,000
Q4 2024

Feb 13, 2025

BUY
$1.82 - $4.4 $161,708 - $390,944
88,851 Added 47.0%
277,892 $511,000
Q3 2024

Nov 13, 2024

BUY
$2.88 - $5.01 $108,578 - $188,882
37,701 Added 24.91%
189,041 $654,000
Q2 2024

Aug 13, 2024

BUY
$2.92 - $5.33 $113,932 - $207,965
39,018 Added 34.74%
151,340 $443,000
Q1 2024

May 13, 2024

BUY
$3.27 - $5.65 $87,423 - $151,052
26,735 Added 31.24%
112,322 $634,000
Q4 2023

Feb 13, 2024

BUY
$2.07 - $4.54 $11,026 - $24,184
5,327 Added 6.64%
85,587 $367,000
Q3 2023

Nov 13, 2023

BUY
$3.29 - $4.9 $2,467 - $3,675
750 Added 0.94%
80,260 $278,000
Q2 2023

Aug 11, 2023

SELL
$4.25 - $5.88 $17,272 - $23,896
-4,064 Reduced 4.86%
79,510 $369,000
Q1 2023

May 11, 2023

SELL
$4.48 - $8.45 $2.42 Million - $4.57 Million
-540,760 Reduced 86.61%
83,574 $386,000
Q4 2022

Feb 13, 2023

SELL
$5.41 - $8.08 $660,674 - $986,737
-122,121 Reduced 16.36%
624,334 $5.04 Million
Q3 2022

Nov 10, 2022

BUY
$5.17 - $7.11 $424,167 - $583,332
82,044 Added 12.35%
746,455 $4.14 Million
Q2 2022

Aug 12, 2022

SELL
$3.41 - $8.95 $249,850 - $655,766
-73,270 Reduced 9.93%
664,411 $3.46 Million
Q1 2022

May 13, 2022

BUY
$7.78 - $15.31 $2,964 - $5,833
381 Added 0.05%
737,681 $6.06 Million
Q2 2021

Aug 13, 2021

BUY
$18.03 - $23.82 $13.3 Million - $17.6 Million
737,300 New
737,300 $13.7 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $42.3M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.